Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dorien Autaers"'
Autor:
Bart Neyns, Sandra Tuyaerts, Ivan Van Riet, Karine Breckpot, Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, Katty Zeven, Dorien Autaers, Ann De Becker, Cleo Goyvaerts, Nick Devoogdt, Yannick De Vlaeminck
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Glioblastoma is the most common lethal primary brain tumor, urging evaluation of new treatment options. Chimeric antigen receptor (CAR)-T cells targeting B7 homolog 3 (B7-H3) are promising because of the overexpression of B7-H3 on glioblas
Externí odkaz:
https://doaj.org/article/3d6525de79f345cf86934422d3e6824d
Autor:
Wout de Mey, Hanne Locy, Kirsten De Ridder, Phaedra De Schrijver, Dorien Autaers, Asma Lakdimi, Arthur Esprit, Lorenzo Franceschini, Kris Thielemans, Magali Verdonck, Karine Breckpot
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Dendritic cell (DC)-maturation stimuli determine the potency of these antigen-presenting cells and, therefore, the quality of the T-cell response. Here we describe that the maturation of DCs via TriMix mRNA, encoding CD40 ligand, a constitutively act
Externí odkaz:
https://doaj.org/article/e9862a7e26b048f78a167d94669c00a0
Autor:
Hanne Locy, Rohann J.M. Correa, Dorien Autaers, Ann Schiettecatte, Jan Jonckheere, Wim Waelput, Louise Cras, Stefanie Brock, Stefaan Verhulst, Keith Kwan, Marian Vanhoeij, Kris Thielemans, Karine Breckpot
Publikováno v:
Biomolecules, Vol 11, Iss 5, p 621 (2021)
The use of gene expression profiling (GEP) in cancer management is rising, as GEP can be used for disease classification and diagnosis, tailoring treatment to underlying genetic determinants of pharmacological response, monitoring of therapy response
Externí odkaz:
https://doaj.org/article/c9bf08f4e0a545e7a6b7fd315d274c6b
Autor:
Wout de Mey, Phaedra De Schrijver, Dorien Autaers, Lena Pfitzer, Bruno Fant, Hanne Locy, Arthur Esprit, Lien Lybaert, Cedric Bogaert, Magali Verdonck, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini
Publikováno v:
Molecular therapy. Nucleic acids. 29
A flexible, affordable, and rapid vaccine platform is necessary to unlock the potential of personalized cancer vaccines in order to achieve full clinical efficiency. mRNA cancer vaccine manufacture relies on the rigid sequence design of multiepitope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b286c02953c326eea9f92a34cb7883a
https://pubmed.ncbi.nlm.nih.gov/36159589
https://pubmed.ncbi.nlm.nih.gov/36159589
Autor:
Rohann J.M. Correa, Dorien Autaers, Jan Jonckheere, Louise Cras, Keith Kwan, Kris Thielemans, Hanne Locy, Marian Vanhoeij, Stefanie Brock, Stefaan Verhulst, Karine Breckpot, A. Schiettecatte, Wim Waelput
Publikováno v:
Biomolecules
Volume 11
Issue 5
Biomolecules, Vol 11, Iss 621, p 621 (2021)
Volume 11
Issue 5
Biomolecules, Vol 11, Iss 621, p 621 (2021)
The use of gene expression profiling (GEP) in cancer management is rising, as GEP can be used for disease classification and diagnosis, tailoring treatment to underlying genetic determinants of pharmacological response, monitoring of therapy response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e08afe00a6f2e69cc9a34652d25097
https://pubmed.ncbi.nlm.nih.gov/33922016
https://pubmed.ncbi.nlm.nih.gov/33922016
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 37:711-714
The purpose of this study was to test a newly developed decontamination and fluidization kit for processing respiratory specimens for the detection of mycobacteria: the Myco-TB procedure (developed by Copan (Brescia, Italy)). This technique was compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c01435dab57ba4f1dd63847e12cfe213
https://doi.org/10.1007/s10096-017-3163-9
https://doi.org/10.1007/s10096-017-3163-9
Autor:
Wout De Mey, Quentin Lecocq, Dorien Autaers, Karine Breckpot, Kris Thielemans, Franceschini L.
Publikováno v:
Vrije Universiteit Brussel
Messenger RNA represents a very attractive therapeutic option for a wide range of clinical applications. Current clinical efforts are focused on vaccination, peptide replacement therapy and treatment of genetic diseases. The clinical translation of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::29d67608c429156faabfc1679709b76c
https://researchportal.vub.be/en/publications/34a0c8bc-8b15-42a4-948a-5dd2e19b45a5
https://researchportal.vub.be/en/publications/34a0c8bc-8b15-42a4-948a-5dd2e19b45a5
